About Isologic

This author has not yet filled in any details.
So far Isologic has created 7 blog entries.

CPDC, New acquisition

2022-11-27T14:05:45-05:00December 1st, 2020|

Dear customers, We are pleased to announce that Isologic has just completed the acquisition of the FDG Canadian distribution business from Centre for Probe Development and Commercialization (CPDC). As a result, all FDG customers serviced by CPDC are, effective December 1st, serviced by Isologic out of our Toronto (Sunnybrook) facility. It has been Isologic corporate [...]


2022-11-27T14:05:54-05:00January 9th, 2020|

Antimony Sulfide Colloid Tc99m injection January 9th, 2020 Dear Valued Customer, It is with great pleasure that we would like to inform you that Isologic has a new product within its portfolio. We are introducing Antimony Sulfide Colloid Tc99m injection. This product is indicated for use as an agent for lymphoscintigraphy and [...]

I-131 Update June 27, 2019

2022-11-27T14:06:02-05:00June 27th, 2019|

I-131 capsule and solution production update June 27th, 2019 Dear Valued Customer, We have been informed by our supplier that the last shipment of Sodium Iodide I-131 products (Therapeutics and Diagnostics) to the Canadian market will be June 26th and no production will occur until July 11th. Our supply of Sodium Iodide [...]

I-131 production update

2022-11-27T14:06:08-05:00June 12th, 2019|

Iodine-131 Diagnostic and Therapeutic capsule production June 7th, 2019 Dear Customer, We would like to inform you that we received information from our vendor of I-131 that their supplier will be in maintenance for a period of 2 weeks starting June 17th. They are working closely with another vendor to minimize the [...]


2022-11-27T14:04:02-05:00May 30th, 2019|

Invitation Special invitation, Monday June 24, 2019 As part of the SNMMI annual conference to be held from June 22 to June 25, ISOLOGIC invites you to a seminar dedicated to innovative radiopharmaceutical services and the production of PET imaging agents. ****First come first serve**** View invitation [...]

Go to Top